Current pharmacologic treatment of multiple sclerosis symptoms
- PMID: 8993211
- PMCID: PMC1303858
Current pharmacologic treatment of multiple sclerosis symptoms
Abstract
About 350,000 persons in the United States have multiple sclerosis, and primary care physicians are often called on to provide symptomatic therapy for these patients. We review our current pharmacologic approach to the management of multiple sclerosis exacerbations and the symptoms of spasticity, fatigue, bladder and bowel involvement, neurobehavioral complaints, pain syndromes, dystonic spasms, and tremor and ataxia.
Comment in
-
Advances in the treatment of multiple sclerosis.West J Med. 1996 Nov;165(5):320-1. West J Med. 1996. PMID: 8993213 Free PMC article. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical